Immunotherapy for human cancer using heat shock protein-peptide complexes

被引：98

作者：

Srivastava P.K. ^{[1
]}

机构：

[1] Ctr. Immunotherapy of Cancer/Infect., University of Connecticut, School of Medicine, Farmington

来源：

Current Oncology Reports | 2005年 / 7卷 / 2期

关键词：

Major Histocompatibility Complex; Heat Shock Protein; Major Histocompatibility Complex Class; Peptide Complex; Mycobacterial Hsp70;

D O I：

10.1007/s11912-005-0035-8

中图分类号：

学科分类号：

摘要：

Heat shock proteins (HSPs) are primordial and abundant molecules expressed in all cells. Publications starting in 1984 have shown that immunization of mice, rats, and frogs with purified preparations of selected HSPs isolated from cancers leads to protective immunity against the cancer used as the source of the HSP. The basis of the tumor-specific immunogenicity of these molecules lies not in the molecules themselves but in the array of peptides, including antigenic peptides chaperoned by them. These experiments and the ideas derived from them form the basis of an approach to immunotherapy for human cancer that began in 1995 and is now in full swing. Copyright © 2005 by Current Science Inc.

引用

页码：104 / 108

页数：4

共 37 条

[1]

Srivastava P., Interaction of heat shock proteins with peptides and antigen presenting cells: Chaperoning of the innate and adaptive immune responses, Annu. Rev. Immunol., 20, pp. 395-425, (2002)

[2]

Srivastava P.K., Udono H., Blachere N.E., Li Z., Heat shock proteins transfer peptides during antigen processing and CTL priming, Immunogenetics, 39, pp. 93-98, (1994)

[3]

Zhu X., Zhao Y., Burkholder W.F., Et al., Structural analysis of substrate binding by the molecular chaperone DnaK, Science, 272, pp. 1606-1614, (1996)

[4]

MacAry P.A., Javid B., Floto R.A., Et al., HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation, Immunity, 20, pp. 95-106, (2004)

[5]

Gidalevitz T., Biswas C., Ding H., Et al., Identification of the N-terminal peptide binding site of glucose-regulated protein 94, J. Biol. Chem., 279, pp. 16543-16552, (2004)

[6]

Baker-LePain J.C., Sarzotti M., Fields T.A., Et al., GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression, J. Exp. Med., 196, pp. 1447-1459, (2002)

[7]

Grossmann M.E., Madden B.J., Gao F., Et al., Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo, Exp. Cell Res., 297, pp. 108-117, (2004)

[8]

Blond-Elguindi S., Cwirla S.E., Dower W.J., Et al., Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP, Cell, 75, pp. 717-728, (1993)

[9]

Podack Yamazaki K., Nguyen T., Podack E.R., Cutting edge: Tumor secreted heat shock-fusion protein elicits CD8 cells for rejection, J. Immunol., 163, pp. 5178-5182, (1999)

[10]

Massa C., Guiducci C., Arioli I., Et al., Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70, Cancer Res., 64, pp. 1502-1508, (2004)

← 1 2 3 4 →